Abstract
Periodontitis is a chronic infectious disease, the course and progression of which are determined by the interaction between microorganisms and the host. Interleukin 1β plays an important role in the destruction of periodontal tissues. Interleukin 1 receptor antagonist (IL-1ra) can inhibit the biological activity of IL-1β without triggering any intracellular signaling. This study aimed to prepare IL-1ra-loaded dextran/PLGA microspheres and evaluate the physical and chemical characteristics and anti-inflammatory properties. Results suggested that the microspheres can be easily prepared into a drug carrier with good biocompatibility and can effectively inhibit the gene expression of pro-inflammatory factors induced by IL-1β in human gingival fibroblasts. Hence, the microspheres are excellent candidate for periodontitis treatment.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-019-01107-w/MediaObjects/10753_2019_1107_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-019-01107-w/MediaObjects/10753_2019_1107_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-019-01107-w/MediaObjects/10753_2019_1107_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-019-01107-w/MediaObjects/10753_2019_1107_Fig4_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-019-01107-w/MediaObjects/10753_2019_1107_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-019-01107-w/MediaObjects/10753_2019_1107_Fig6_HTML.png)
Similar content being viewed by others
References
Slots, J. 2017. Periodontitis: facts, fallacies and the future. Periodontology 2000 75 (1): 7–23.
Cochran, D.L. 2008. Inflammation and bone loss in periodontal disease. Journal of Periodontology 79 (8): 1569–1576.
Dayan, S., P. Stashenko, R. Niederman, and T.S. Kupper. 2004. Oral epithelial overexpression of IL-1alpha causes periodontal disease. Journal of Dental Research 83: 86–90.
Kida, Y., M. Kobayashi, T. Suzuki, A. Takeshita, Y. Okamatsu, S. Hanazawa, T. Yasui, and K. Hasegawa. 2005. Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kB in human gingival fibroblasts. Cytokine 29: 159–168.
Boukortt, K.N., N. Saidi-Ouahrani, B. Boukerzaza, H. Ouhaibi-Djellouli, K. Hachmaoui, F.Z. Benaissa, L. Taleb, H. Drabla-Ouahrani, T. Deba, S.A. Ouledhamou, N. Mehtar, and A. Boudjema. 2015. Association analysis of the IL-1 gene cluster polymorphisms with aggressive and chronic periodontitis in the Algerian population. Archives of Oral Biology 60 (10): 1463–1470.
BochJ, A., N. Wara-aswapati, and P.E. Auron. 2001. Interleukin 1 signal transduction–current concepts and relevance to periodontitis. Journal of Dental Research 80: 400–407.
Kinane, D.F., and D.F. Lappin. 2001. Clinical, pathological and immunological aspects of periodontal disease. Acta Odontologica Scandinavica 59: 154–160.
Delima, A.J., S. Karatzas, S. Amar, and D.T. Graves. 2002. Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists. The Journal of Infectious Diseases 186 (4): 511–516.
Dinarello, C.A., and J.W. van der Meer. 2013. Treating inflammation by blocking interleukin-1 in humans. Seminars in Immunology 25 (6): 469–484.
Chevalier, X., P. Goupille, A.D. Beaulieu, F.X. Burch, W.G. Bensen, T. Conrozier, D. Loeuille, A.J. Kivitz, D. Silver, and B.E. Appleton. 2009. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis and Rheumatism 61 (3): 344–352.
Lust, J.A., M.Q. Lacy, S.R. Zeldenrust, A. Dispenzieri, M.A. Gertz, T.E. Witzig, S. Kumar, S.R. Hayman, S.J. Russell, F.K. Buadi, S.M. Geyer, M.E. Campbell, R.A. Kyle, S.V. Rajkumar, P.R. Greipp, M.P. Kline, Y. Xiong, L.L. Moon-Tasson, and K.A. Donovan. 2009. Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component. Mayo Clinic Proceedings 84 (2): 114–122.
Mertens, M., and J.A. Singh. 2009. Anakinra for rheumatoid arthritis: a systematic review. The Journal of Rheumatology 36 (6): 1118–1125.
Shakoory, B., J.A. Carcillo, W.W. Chatham, R.L. Amdur, H. Zhao, C.A. Dinarello, R.Q. Cron, and S.M. Opal. 2016. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III Trial. Critical Care Medicine 44 (2): 275–281.
Quartier, P., F. Allantaz, R. Cimaz, P. Pillet, C. Messiaen, C. Bardin, X. Bossuyt, A. Boutten, J. Bienvenu, A. Duquesne, O. Richer, D. Chaussabel, A. Mogenet, J. Banchereau, J.M. Treluyer, P. Landais, and V. Pascual. 2011. A multicentre, randomised, double-blind, placebo controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Annals of the Rheumatic Diseases 70 (5): 747–754.
Rawlinson, A., M.H. Dalati, S. Rahman, T.F. Walsh, and A.L. Fairclough. 2000. Interleukin-1 and IL-1 receptor antagonist in gingival crevicular fluid. Journal of Clinical Periodontology 27: 738–743.
Ishihara, Y., T. Nishihara, and T. Kuroyanagi. 1997. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. Journal of Periodontal Research 32: 524–529.
Izawa, A., Y. Ishihara, H. Mizutani, S. Kobayashi, H. Goto, E. Okabe, H. Takeda, Y. Ozawa, Y. Kamiya, Y. Sugita, K. Kubo, H. Kamei, T. Kikuchi, A. Mitani, J. Hayashi, T. Nishihara, H. Maeda, and T. Noguchi. 2014. Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice. Infection and Immunity 82 (5): 1904–1913.
Yucesoy, B., R. Peila, L.R. White, K.M. Wu, V.J. Johnson, M.L. Kashon, M.I. Luster, and L.J. Launer. 2006. Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study. Neurobiology of Aging 27 (2): 211–217.
Delima, A.J., T. Oates, R. Assuma, Z. Schwartz, D. Cochran, S. Amar, and D.T. Graves. 2001. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachmentin experimental periodontitis. Journal of Clinical Periodontology 28 (3): 233–240.
Jin, L., X. Zeng, M. Liu, Y. Deng, and N. He. 2014. Current progress in gene delivery technology based on chemical methods and nano-carriers. Theranostics 4 (3): 240–255.
Aldayel, A.M., Y.W. Naguib, H.L. O'Mary, X. Li, M. Niu, T.B. Ruwona, and Z. Cui. 2016. Acid-sensitive sheddable PEGylated PLGA nanoparticles increase the delivery of TNF-alpha siRNA in chronic inflammation sites. Molecular Therapy--Nucleic Acids 5 (7): 340.
Park, J.S., H.N. Yang, S.W. Yi, J.H. Kim, and K.H. Park. 2016. Neoangiogenesis of human mesenchymal stem cells transfected with peptide-loaded and gene-coated PLGA nanoparticles. Biomaterials 76: 226–237.
Kang, J., F. Wu, Y. Cai, M. Xu, M. He, and W. Yuan. 2014. Development of recombinant human growth hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method. European Journal of Pharmaceutical Sciences 62: 141–147.
Utzinger, M., A. Jarzebinska, N. Haag, M. Schweizer, G. Winter, C. Dohmen, C. Rudolph, and C. Plank. 2017. cmRNA/lipoplex encapsulation in PLGA microspheres enables transfection via calcium phosphate cement (CPC)/PLGA composites. Journal of Controlled Release 249: 143–149.
Zhou, J., and L.J. Windsor. 2007. Heterogeneity in the collagen-degrading ability of Porphyromonas gingivalis-stimulated human gingival fibroblasts. Journal of Periodontal Research 42 (1): 77–84.
Smith, L.J., J.A. Chiaro, N.L. Nerurkar, D.H. Cortes, S.D. Horava, N.M. Hebela, R.L. Mauck, G.R. Dodge, and D.M. Elliott. 2011. Nucleus pulposus cells synthesize a functional extracellular matrix and respond to inflammatory cytokine challenge following long-term agarose culture. European Cells & Materials 22: 291–301.
Gorth, D.J., R.L. Mauck, J.A. Chiaro, B. Mohanraj, N.M. Hebela, G.R. Dodge, D.M. Elliott, and L.J. Smith. 2012. IL-1ra delivered from poly(lactic-co-glycolic acid) microspheres attenuates IL-1β-mediated degradation of nucleus pulposus in vitro. Arthritis Research & Therapy 14 (4): R179.
Liang, Di, Fu Xiujuan, and Meiling Liao. 2013. Development of dextran microparticles loaded with IL-1Ra of high-encapsulation efficiency and high-bioactivity by a novel method without exposing IL-1Ra to water-oil interfaces. Powder Technology 235: 299–302.
Wu, F., L. Dai, L. Geng, H. Zhu, and T. Jin. 2017. Practically feasible production of sustained-release microspheres of granulocytemacrophage colony-stimulating factor (rhGM–CSF). Journal of Controlled Release 259: 195–202.
Geng, Y., W. Yuan, F. Wu, J. Chen, M. He, and T. Jin. 2008. Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation. Journal of Controlled Release 130: 259–265.
Sawada, S., N. Chosa, A. Ishisaki, and K. Naruishi. 2013. Enhancement of gingival inflammation induced by synergism of IL-1β and IL-6. Biomedical Research 34: 31–40.
Xing, L., T.P. Bushnell, L. Carlson, Z. Tai, M. Tondravi, U. Siebenlist, F. Young, and B.F. Boyce. 2002. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. Journal of Bone and Mineral Research 17 (7): 1200–1210.
Kondo, A., T. Otsuka, R. Matsushima-Nishiwaki, G. Kuroyanagi, J. Mizutani, I. Wada, O. Kozawa, and H. Tokuda. 2013. Inhibition of SAPK/JNK leads to enhanced IL-1-induced IL-6 synthesis in osteoblasts. Archives of Biochemistry and Biophysics 15;535 (2): 227–233.
Deo, V., and M.L. Bhongade. 2010. Pathogenesis of periodontitis: role of cytokines in host response. Dentistry Today 29 (9): 60–62 64-6; quiz 68-9.
Shindo, S., Y. Hosokawa, I. Hosokawa, K. Ozaki, and T. Matsuo. 2014. Genipin inhibits MMP-1 and MMP-3 release from TNF-a-stimulated human periodontal ligament cells. Biochimie 107: 391–395.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The Ethics Committee of Hospital of Stomatology, Jilin University, granted permission to allow the gingival tissues to be removed for HGF, isolation, and culture.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lu, J., Ren, B., Wang, L. et al. Preparation and Evaluation of IL-1ra-Loaded Dextran/PLGA Microspheres for Inhibiting Periodontal Inflammation In Vitro. Inflammation 43, 168–178 (2020). https://doi.org/10.1007/s10753-019-01107-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-019-01107-w